Nuvectis Pharma (NVCT) SEC Filings & 10K Form $5.07 -0.07 (-1.36%) (As of 11/20/2024 ET) Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Recent Nuvectis Pharma SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView11/18/20247:30 AMBENTSUR RON (Reporting)Nuvectis Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 11/08/20242:59 PMCarson Michael J. (Reporting)Nuvectis Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 11/05/20249:55 AMNuvectis Pharma (Subject)Pontifax Management 4 G.P. Ltd. (0001726334) (Filed by)Form SC 13G/A11/05/20247:31 AMNuvectis Pharma (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 11/05/20246:08 AMNuvectis Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/29/20247:52 AMNuvectis Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/13/20243:09 PMNuvectis Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/15/20248:16 AMBENTSUR RON (Reporting)Nuvectis Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 05/13/20247:47 AMNuvectis Pharma (Issuer)Shemesh Shay (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/13/20247:49 AMNuvectis Pharma (Issuer)Poradosu Enrique (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/13/20247:51 AMBENTSUR RON (Reporting)Nuvectis Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 05/07/20248:13 AMNuvectis Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/19/20247:00 AMBENTSUR RON (Reporting)Nuvectis Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 03/05/20244:20 PMNuvectis Pharma (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 03/05/20247:17 AMNuvectis Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/28/20247:37 AMMosseri Marlio Charles (Filed by)Nuvectis Pharma (Subject)Form SC 13G/A02/06/20247:47 AMNuvectis Pharma (Subject)Pontifax Management 4 G.P. Ltd. (0001726334) (Filed by)Form SC 13G01/30/20248:01 PMNuvectis Pharma (Subject)Peters Thomas Phineas (Filed by)Form SC 13G/A01/05/20243:30 PMNuvectis Pharma (Issuer)Shemesh Shay (Reporting)Form 4Statement of changes in beneficial ownership of securities 01/05/20243:31 PMNuvectis Pharma (Issuer)Poradosu Enrique (Reporting)Form 4Statement of changes in beneficial ownership of securities (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies AKBA SEC Filings KALV SEC Filings ALEC SEC Filings VALN SEC Filings DNA SEC Filings AMLX SEC Filings QTTB SEC Filings CTNM SEC Filings CYRX SEC Filings KMDA SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:NVCT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvectis Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvectis Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVCT Stock Alerts